Cancer Family
Digestive System Neoplasm
CI-CAN-00000012Explore in graph →
Non-malignant4,734 active trials43 approved drugs557 evidence items
Loading cancer entity…
Cancer Family
CI-CAN-00000012Explore in graph →
Clinical trials
22,061 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT07449637 | Real-World Treatment Patterns and Survival Outcomes in Patients With Intermediate-Stage Hepatocellular Carcinoma. | not yet recruiting | — | 200 | Sohag UniversityOTHER | 1 | Mar 4, 2026 | clinicaltrials |
| NCT07444840 | How Does Pre-operative Biliary Drainage in Pancreatic Adenocarcinoma Affect Surgical Outcomes in Pancreatic Cancer Surgery(PBDSOO) | not yet recruiting | — | 90 | East Lancashire Hospitals NHS TrustOTHER |
| 0 |
| Mar 3, 2026 |
| clinicaltrials |
| NCT07446335 | A Phase III Study of First-line Anlotinib Combined With Benmelstobart in Patients With Advanced Esophageal Squamous Cell Carcinoma | not yet recruiting | Phase 3 | 578 | The First Affiliated Hospital of Zhengzhou UniversityOTHER | 1 | Mar 3, 2026 | clinicaltrials |
| NCT07446465 | FOLFOX Chemotherapy Combined With Fruquintinib and Serplulimab as First-Line Conversion Therapy for Initially Unresectable pMMR/MSS Colorectal Cancer | not yet recruiting | Phase 4 | 42 | Ye XuOTHER | 1 | Mar 3, 2026 | clinicaltrials |
| NCT07435584 | Everolimus in CDK12-Deficient Metastatic Colorectal Cancer (EVER-RECODE)(EVER-RECODE) | not yet recruiting | Phase 1 / Phase 2 | 38 | Second Affiliated Hospital, Zhejiang University, School of MedicineOTHER | 0 | Feb 27, 2026 | clinicaltrials |
| NCT07437287 | Testing Mitazalimab in Combination With Standard Chemotherapy in Immunotherapy Resistant Advanced Biliary Tract Cancers(CROCOBIL) | not yet recruiting | Phase 2 / Phase 3 | 160 | UNICANCEROTHER | 1 | Feb 27, 2026 | clinicaltrials |
| NCT07437326 | Food-related Quality of Life in Patients With Cancer(QVA-Mod) | not yet recruiting | — | 180 | Hospices Civils de LyonOTHER | 1 | Feb 27, 2026 | clinicaltrials |
| NCT07438418 | An Observational Study on Gastric Cancer in High-risk Individuals | not yet recruiting | — | 3,000 | Fudan UniversityOTHER | 1 | Feb 27, 2026 | clinicaltrials |
| NCT07440212 | Clinical Study on Noninvasive Evaluation of Ivonescimab Antibody Distribution and Expression in Esophageal Cancer Patients by 89Zr-AK112 PET Imaging | not yet recruiting | — | 50 | Daping Hospital and the Research Institute of Surgery of the Third Military Medical UniversityOTHER | 1 | Feb 27, 2026 | clinicaltrials |
| NCT06943794 | Eradication of Helicobacter Pylori Subtypes at High Gastric Cancer Risk: a Cluster-randomized Controlled Trial | not yet recruiting | N/A | 4,824 | Fudan UniversityOTHER | 1 | Feb 25, 2026 | clinicaltrials |
| NCT07432568 | A Study of Liposomal Irinotecan Plus 5-FU/LV HAIC With Lenvatinib and a PD-1 Inhibitor in Advanced ICC | not yet recruiting | Phase 2 | 30 | Tianjin Medical University Cancer Institute and HospitalOTHER | 0 | Feb 25, 2026 | clinicaltrials |
| NCT07429643 | Endoscopic Ultrasound-Guided Loco-regional Chemotherapy Injection as Adjuvant Therapy for Locally Advanced Pancreatic Cancer. | not yet recruiting | Phase 2 / Phase 3 | 20 | Assiut UniversityOTHER | 0 | Feb 24, 2026 | clinicaltrials |
| NCT06958224 | Theranostic Approach by Early Multigene Sequencing in Advanced Poor Prognosis Cancers(ESCAT) | not yet recruiting | N/A | 360 | University Hospital, LilleOTHER | 0 | Feb 20, 2026 | clinicaltrials |
| NCT07409844 | Neoadjuvant Immunotherapy and Organ-sparing Treatment in Patients With Stage I-III dMMR Colon Cancer(RESET C2) | not yet recruiting | Phase 2 | 152 | Ismail GögenurOTHER | 1 | Feb 20, 2026 | clinicaltrials |
| NCT07420010 | An Open-label, Single-arm Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetic Profile, and Preliminary Efficacy of KT032 Cell Injection in Patients With Mesothelin-positive Advanced Solid Tumors. | not yet recruiting | Early Phase 1 | 24 | Weijia Fang, MDOTHER | 0 | Feb 19, 2026 | clinicaltrials |
| NCT07422103 | PAN-CLO-BU (PANcreas-CLOstridium-BUtyricum)(PAN-CLO-BU) | not yet recruiting | N/A | 158 | Casa di Cura Dott. PederzoliOTHER | 1 | Feb 19, 2026 | clinicaltrials |
| NCT07410767 | Advanced Endoscopic Resections for Rectal Neoplasms | not yet recruiting | — | 300 | Jagiellonian UniversityOTHER | 1 | Feb 18, 2026 | clinicaltrials |
| NCT07297615 | 3D Liver Volumetry | not yet recruiting | N/A | 25 | Medical University of GrazOTHER | 1 | Feb 17, 2026 | clinicaltrials |
| NCT07361575 | Study Comparing the Quality of Colon Cleanliness With Prepackaged LRD (Low-residue Diet) vs. Guided (POG).(POG) | not yet recruiting | N/A | 230 | Clinique Paris-BercyOTHER | 1 | Feb 17, 2026 | clinicaltrials |
| NCT07411781 | PIN in Combination With Sintilimab in Previously Treated pMMR/MSS CRC With Hepatic Metastases | not yet recruiting | Phase 1 | 25 | Chinese PLA General HospitalOTHER | 1 | Feb 17, 2026 | clinicaltrials |
| NCT07412054 | Lenvatinib and Pembrolizumab With or Without BCAA in Unresectable HCC(BLP-HCC) | not yet recruiting | Phase 2 | 234 | Fudan UniversityOTHER | 0 | Feb 17, 2026 | clinicaltrials |
| NCT07413146 | Neoadjuvant CAPEOX Versus Upfront Surgery for Locally Advanced Colon Cancer With Elevated CEA: A Single-Center, Open-Label, Randomized Controlled Trial | not yet recruiting | N/A | 100 | Sun Yat-sen UniversityOTHER | 0 | Feb 17, 2026 | clinicaltrials |
| NCT07414082 | Serum Talin-1 and Cripto-1 in Colorectal Cancer(Talin-1/CR-1) | not yet recruiting | N/A | 70 | Assiut UniversityOTHER | 1 | Feb 17, 2026 | clinicaltrials |
| NCT07414433 | Validation of Blood-Based Biomarkers in TACE-Treated Hepatocellular Carcinoma(BLOOD-TACE-M) | not yet recruiting | — | 60 | University of BelgradeOTHER | 1 | Feb 17, 2026 | clinicaltrials |
| NCT07415525 | IBI343 Combined With Chemotherapy as Neoadjuvant Therapy in Borderline Resectable Pancreatic Cancer | not yet recruiting | Phase 2 | 40 | Zhejiang UniversityOTHER | 1 | Feb 17, 2026 | clinicaltrials |
| NCT07410546 | Quantitative Fecal Immunochemical Test for Detection of Colorectal Cancer and Precancerous Lesions in Sohag | not yet recruiting | — | 150 | Sohag UniversityOTHER | 0 | Feb 13, 2026 | clinicaltrials |
| NCT07410715 | Surgery vs. Watch-and-Wait Strategy in Complete Responders for Hepatocellular Carcinoma (SWITCH)(SWITCH) | not yet recruiting | — | 100 | West China HospitalOTHER | 0 | Feb 13, 2026 | clinicaltrials |
| NCT07398456 | Smartphone-enabled Hybrid Identification of Early CoLorectal Disease Using Blood-Based Cancer Testing Across TeXas(SHIELD-TX) | not yet recruiting | N/A | 5,500 | Baylor Research InstituteOTHER | 1 | Feb 12, 2026 | clinicaltrials |
| NCT07405736 | Lubiprostone Combined With Maintenance Therapy for Prevention of Postoperative Recurrence in Peritoneal Metastatic Colorectal Cancer | not yet recruiting | Phase 2 | 124 | Sun Yat-sen UniversityOTHER | 0 | Feb 12, 2026 | clinicaltrials |
| NCT07406269 | Clinical Evaluation of AI Decision Support for Early Rehabilitation After Surgery(DESIRE) | not yet recruiting | N/A | 103 | Erasmus Medical CenterOTHER | 1 | Feb 12, 2026 | clinicaltrials |
| NCT07406815 | The Value of Near-Infrared Fluorescence Imaging in the Protection of the Recurrent Laryngeal Nerve During Minimally Invasive Esophagectomy | not yet recruiting | Phase 3 | 144 | Fujian Medical University Union HospitalOTHER | 1 | Feb 12, 2026 | clinicaltrials |
| NCT07406958 | Advanced Classification of Colon Tumors From CT Scans Using Deep Learning for Optimized Treatment Decision-making.(DeepColScan) | not yet recruiting | — | 1,000 | Assistance Publique - Hôpitaux de ParisOTHER | 1 | Feb 12, 2026 | clinicaltrials |
| NCT06615830 | Predictive Value of Transcriptome-based OncoTreat/Oncotarget and Organoid Testing in Metastatic Pancreatic Cancer. | not yet recruiting | — | 185 | Prof. Dr. med. Dres. h.c. Jan Schmidt, MMEOTHER | 0 | Feb 11, 2026 | clinicaltrials |
| NCT07397442 | Short-Course Radiotherapy Combined With Chemotherapy and Immunotherapy in Mid-Low Locally Advanced Rectal Cancer | not yet recruiting | Phase 2 | 19 | Beijing Friendship HospitalOTHER | 1 | Feb 11, 2026 | clinicaltrials |
| NCT07402486 | A Phase II Prospective Study of Maastro Applicator Brachytherapy for Rectal Cancer | not yet recruiting | Phase 2 | 20 | Siriraj HospitalOTHER | 0 | Feb 11, 2026 | clinicaltrials |
| NCT07403435 | Short-course Radiotherapy Combined With Serplulimab and Chemotherapy as Neoadjuvant Treatment for Resectable ESCC | not yet recruiting | Phase 2 | 22 | Union Hospital, Tongji Medical College, Huazhong University of Science and TechnologyOTHER | 1 | Feb 11, 2026 | clinicaltrials |
| NCT07403877 | Neoadjuvant Immunotherapy ± Radiotherapy in MSI-H/dMMR Locally Advanced Colorectal Cancer(TORCH-OPTIMA) | not yet recruiting | Phase 2 | 114 | Fudan UniversityOTHER | 1 | Feb 11, 2026 | clinicaltrials |
| NCT07392866 | A Clinical Study of SH006 Injection in Combination Therapy Versus Regorafenib in the Treatment of Advanced Hepatocellular Carcinoma | not yet recruiting | Phase 2 / Phase 3 | 120 | Nanjing Sanhome Pharmaceutical, Co., Ltd.INDUSTRY | 1 | Feb 9, 2026 | clinicaltrials |
| NCT07395063 | A Clinical Study on the Treatment of Metastatic Colorectal Cancer at the Second-line or Beyond. | not yet recruiting | Phase 2 | 68 | The Fourth Affiliated Hospital of Zhejiang University School of MedicineOTHER | 0 | Feb 9, 2026 | clinicaltrials |
| NCT07386431 | The Association Between Deep Endometriosis and the Occurrence of Colorectal Carcinoma | not yet recruiting | — | 30 | University Medical Centre LjubljanaOTHER | 0 | Feb 6, 2026 | clinicaltrials |
| NCT07391566 | LPM6690176 in Combination With Chemotherapy and Bevacizumab in Metastatic Colorectal Cancer Patients With RAS Mutation | not yet recruiting | Phase 1 / Phase 2 | 99 | Luye Pharma Group Ltd.INDUSTRY | 1 | Feb 6, 2026 | clinicaltrials |
| NCT07391826 | Megestrol Acetate Oral Suspension for Cachexia in Patients With cStage III Gastric/Gastroesophageal Junction Adenocarcinoma Receiving Neoadjuvant Therapy With Serplulimab Combined With SOX | not yet recruiting | Phase 2 | 48 | The First Affiliated Hospital with Nanjing Medical UniversityOTHER | 1 | Feb 6, 2026 | clinicaltrials |
| NCT07394192 | Short-Course Radiotherapy With Tumor-Draining Lymph Node Preservation Followed by PD-1 Inhibitors in pMMR/MSS Stage II-III Rectal Cancer(PKUCH- R11) | not yet recruiting | Phase 2 | 44 | Peking University Cancer Hospital & InstituteOTHER | 0 | Feb 6, 2026 | clinicaltrials |
| NCT07394205 | Clinical Study of CBG131 CAR-T Cell Injection for the Treatment of CLDN18.2-Positive Advanced Gastric and Pancreatic Cancer | not yet recruiting | Early Phase 1 | 18 | First Affiliated Hospital of Wenzhou Medical UniversityOTHER | 1 | Feb 6, 2026 | clinicaltrials |
| NCT06203821 | Study of Perioperative NP137 and FOLFIRINOX in Resectable Pancreatic Cancer | not yet recruiting | Phase 1 | 25 | Aram HezelOTHER | 1 | Feb 5, 2026 | clinicaltrials |
| NCT07383922 | A Study of FG-M108+Chemotherapy vs Placebo+Chemotherapy in Claudin18.2-positive Pancreatic Cancer | not yet recruiting | Phase 3 | 524 | FutureGen Biopharmaceutical (Beijing) Co., LtdINDUSTRY | 1 | Feb 4, 2026 | clinicaltrials |
| NCT07385664 | Neoadjuvant Chemoimmunotherapy or Chemoradiotherapy in ESCC(FAIR) | not yet recruiting | Phase 2 | 66 | Ji YonglingOTHER | 1 | Feb 4, 2026 | clinicaltrials |
| NCT07376668 | Effects of a WhatsApp-assisted Prehabilitation for Patient Undergoing Elective Colorectal Cancer Surgery | not yet recruiting | N/A | 100 | Tseung Kwan O Hospital, Hong KongOTHER | 1 | Feb 3, 2026 | clinicaltrials |
| NCT07381400 | Neoadjuvant mFOLFOX6 Chemotherapy Combined With Anti-PD-1 Therapy in MSS/pMMR Locally Advanced Rectal Cancer (FIRM02 Study) | not yet recruiting | Phase 2 | 128 | Xinhua Hospital, Shanghai Jiao Tong University School of MedicineOTHER | 0 | Feb 3, 2026 | clinicaltrials |
Data updated 24 days agoSource updated Mar 4, 2026source: clinicaltrials